BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 26725515)

  • 1. Mechanism of FGF receptor dimerization and activation.
    Sarabipour S; Hristova K
    Nat Commun; 2016 Jan; 7():10262. PubMed ID: 26725515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
    Sarabipour S; Hristova K
    Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1436-42. PubMed ID: 27040652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
    Li E; You M; Hristova K
    Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The strong dimerization of the transmembrane domain of the fibroblast growth factor receptor (FGFR) is modulated by C-terminal juxtamembrane residues.
    Peng WC; Lin X; Torres J
    Protein Sci; 2009 Feb; 18(2):450-9. PubMed ID: 19165726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGFR3 unliganded dimer stabilization by the juxtamembrane domain.
    Sarabipour S; Hristova K
    J Mol Biol; 2015 Apr; 427(8):1705-14. PubMed ID: 25688803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.
    Chellaiah A; Yuan W; Chellaiah M; Ornitz DM
    J Biol Chem; 1999 Dec; 274(49):34785-94. PubMed ID: 10574949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
    Safran M; Eisenstein M; Aviezer D; Yayon A
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):107-13. PubMed ID: 10600645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
    Ibrahimi OA; Yeh BK; Eliseenkova AV; Zhang F; Olsen SK; Igarashi M; Aaronson SA; Linhardt RJ; Mohammadi M
    Mol Cell Biol; 2005 Jan; 25(2):671-84. PubMed ID: 15632068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
    Sarabipour S; Del Piccolo N; Hristova K
    Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
    Lopez ME; Korc M
    J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for fibroblast growth factor receptor activation.
    Mohammadi M; Olsen SK; Ibrahimi OA
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.
    Plotnikov AN; Hubbard SR; Schlessinger J; Mohammadi M
    Cell; 2000 May; 101(4):413-24. PubMed ID: 10830168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1.
    Beenken A; Eliseenkova AV; Ibrahimi OA; Olsen SK; Mohammadi M
    J Biol Chem; 2012 Jan; 287(5):3067-78. PubMed ID: 22057274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physical basis of FGFR3 response to fgf1 and fgf2.
    Chen F; Hristova K
    Biochemistry; 2011 Oct; 50(40):8576-82. PubMed ID: 21894939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for FGF receptor dimerization and activation.
    Plotnikov AN; Schlessinger J; Hubbard SR; Mohammadi M
    Cell; 1999 Sep; 98(5):641-50. PubMed ID: 10490103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural interactions of fibroblast growth factor receptor with its ligands.
    Stauber DJ; DiGabriele AD; Hendrickson WA
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):49-54. PubMed ID: 10618369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs.
    Terada M; Shimizu A; Sato N; Miyakaze SI; Katayama H; Kurokawa-Seo M
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):365-73. PubMed ID: 11703096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding.
    Huhtala MT; Pentikäinen OT; Johnson MS
    Structure; 1999 Jun; 7(6):699-709. PubMed ID: 10404599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.